3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
21
Lymphoma, Mantle-Cell
15
Lymphoma, Non-Hodgkin
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma
5
Lymphoma, B-Cell
3
Leukemia, B-Cell
3
Waldenstrom Macroglobulinemia
2
Lymphatic Diseases
2
Neoplasms
1
Neoplasm, Residual
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Prolymphocytic
1
Leukemia, Hairy Cell
1
Hodgkin Disease
1
Hematologic Diseases
1
Heart Failure
1
Glioblastoma
1
Burkitt Lymphoma
1
Anemia, Hemolytic, Autoimmune
1
Interventions
Cyclophosphamide
2
pembrolizumab
1
ibrutinib
1
fludarabine phosphate
1
fludarabine
1
Whole-Body Irradiation
1
Tacrolimus
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
CLR1404
1
CA-4948
1
Busulfan
1
Bone Marrow Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoproliferative Disorders
×
acalabrutinib
×
90 days
×
Clear all
No trials found.